Blacher, Eran

Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection

Thaiss, C. A., Levy, M., Grosheva, I., Zheng, D., Soffer, E., Blacher, E., Braverman, S., Tengeler, A. C., Barak, O., Elazar, M., et al. (2018) · Science

Gut microbiota and healthGastrointestinal motility and disorders

Cited by 942

Potential roles of gut microbiome and metabolites in modulating ALS in mice

Blacher, E., Bashiardes, S., Shapiro, H., Rothschild, D., Mor, U., Dori-Bachash, M., Kleimeyer, C., Moresi, C., Harnik, Y., Zur, M., et al. (2019) · Nature

Gut microbiota and healthAmyotrophic Lateral Sclerosis Research

Cited by 700

Our gut microbiome: The evolving inner self

Kundu, P., Blacher, E., Elinav, E., & Pettersson, S. (2017) · Cell

Gut microbiota and healthOral microbiology and periodontitis research

Cited by 633

Microbiome-modulated metabolites at the interface of host immunity

Blacher, E., Levy, M., Tatirovsky, E., & Elinav, E. (2017) · The Journal of Immunology

Gut microbiota and healthMetabolomics and Mass Spectrometry Studies

Cited by 354

Alzheimer's disease pathology is attenuated in a CD 38‐deficient mouse model

Blacher, E., Dadali, T., Bespalko, A., Haupenthal, V. J., Grimm, M. O. W., Hartmann, T., Lund, F. E., Stein, R., & Levy, A. (2015) · Annals of Neurology

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 117